Shuttle Pharmaceuticals Holdings (SHPH) Other Working Capital Changes (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Other Working Capital Changes of $1.2 million in Q1 2026, up 1100.82% quarter-over-quarter from -$120312.0 in Q4 2025, and up 576224.88% on a YoY basis from N/an in Q1 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Other Working Capital Changes history runs 6 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 576224.88% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $1.1 million (up 278362.98% YoY), while the FY2025 annual figure was -$121867.0, down 42710.84% from the prior year.
- Other Working Capital Changes was $1.2 million for Q1 2026 at Shuttle Pharmaceuticals Holdings, up from -$120312.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.2 million in Q1 2026 to a low of -$120312.0 in Q4 2025.
- Historically, Other Working Capital Changes has averaged $73811.9 across 5 years, with a median of -$212.0 in 2024.
- The sharpest annual moves came in 2025 and 2026: Other Working Capital Changes plunged 56650.94% in 2025, then jumped 576224.88% in 2026.
- A 5-year view of Other Working Capital Changes shows it stood at $160268.0 in 2022, then slumped by 95.86% to $6643.0 in 2023, then plunged by 103.19% to -$212.0 in 2024, then slumped by 56650.94% to -$120312.0 in 2025, then soared by 1100.82% to $1.2 million in 2026.
- The last three Other Working Capital Changes figures came in at $1.2 million (Q1 2026), -$120312.0 (Q4 2025), and -$905.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 2.17 Mn | 1.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.20 Mn |
| Mar 31, 2026 | 1.20 Mn |
| Dec 31, 2025 | -120,312.00 |
| Dec 31, 2025 | -120,312.00 |
| Sep 30, 2025 | -905.00 |
| Sep 30, 2025 | -905.00 |
| Jun 30, 2025 | -441.00 |
| Jun 30, 2025 | -441.00 |
| Mar 31, 2025 | -209.00 |
| Mar 31, 2025 | -209.00 |
| Dec 31, 2024 | -212.00 |
| Dec 31, 2024 | -212.00 |
| Sep 30, 2024 | -24,547.00 |
| Sep 30, 2024 | -24,547.00 |
| Jun 30, 2024 | 24,579.00 |
| Jun 30, 2024 | 24,579.00 |
| Mar 31, 2024 | 466.00 |
| Mar 31, 2024 | 466.00 |
| Dec 31, 2023 | 6,643.00 |
| Dec 31, 2023 | 6,643.00 |